Moderna CEO announces development of combined COVID-19/flu vaccine In some years, flu vaccines are only 30 percent effective.

David McLoone | lifesitenews.com

American biotechnology company Moderna, developer of one of the country’s two mRNA experimental vaccines for COVID-19, has announced plans to create a hybrid vaccine that will target both COVID and influenza, again using its new mRNA technology.

Read More: Moderna CEO announces development of combined COVID-19/flu vaccine

This entry was posted in Agenda 21/Great Reset, Genome, Headlines, Health Related, Science, Society, Vaccinations and tagged , , , , , . Bookmark the permalink.